Nicole Lambert, See Remarks at MYRIAD GENETICS INC (MYGN), sold 1,420 shares at $31.57 ($45K) on 2021-10-01, disclosed to the SEC on 2021-10-04.
Scheduled sale ($45k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MYGN | SELL | 2021-09-27 | $669K | — | Filing → |
| MYGN | SELL | 2021-08-30 | $33K | — | Filing → |
| MYGN | SELL | 2021-04-20 | $339K | — | Filing → |